ArticleNature immunology2022
An engineered bispecific human monoclonal antibody against SARS-CoV-2.
Zhaohui Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
this papercites it
ArticleNature immunology2022
Zhaohui Li et al.PubMed ↗Publisher ↗
No numbers read from the abstract.